Grieve, Stacy <br/><br/>
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10.  [electronic resource] 

 -  ESMO open  03 2020 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>2059-7029 
<br/><br/><label>Standard No.: </label>10.1136/esmoopen-2020-000679  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Female<br/>Humans<br/>Immunohistochemistry--methods<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Transcriptome--genetics